MarketInOut Stock Screener Log In | Sign Up
 

Beta Bionics Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/22/2026 16:00
Beta Bionics Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization882.02 mln
Float44.94 mln
Earnings Date10/27/2026

Beneish M-Score

-2.24
Borderline

1-Year Forecast

24.24
Strong upside

Relative Strength

94 / 100
Top performer

Debt / Equity

0.03
Debt-free

Pre-Tax Margin

-61%
Severely loss-making

ROE

-25.85
Deeply negative

Business Description

Beta Bionics makes medical devices that help people with diabetes manage their insulin automatically. Its main product, the iLet Bionic Pancreas, handles insulin delivery on its own for adults and children as young as six who have type 1 diabetes. The company is working on several new products, including a tubeless patch pump, a device that delivers both insulin and glucagon, and a version of iLet designed for type 2 diabetes patients. Founded in 2015 and based in Irvine, California, Beta Bionics works alongside Abbott Diabetes Care and Xeris Pharmaceuticals to bring these solutions to market.

Key Fundamentals

EPS-1.64
ROE-25.85
RPS2.69
ROIC-90.38
ROA-23.01
EBITDA, mln-69.65
EV / EBITDA-12.31
EV / EBIT-11.75
Revenue, mln119
EV / Revenue7.21

Quote Details

Last 19.34
Change 0.94 (5.11%)
Open 18.40
Volume 685,199
Turnover 13,251,749
Average Volume 1,014,754

Financial Ratios

Pre-Tax Profit Margin-61
Leverage Ratio1.14
Current Ratio8.88
Price / Book3.38
Price / Tangible Book3.38
Debt / Equity0.03
Price / Sales7.14

Financial Strength

Altman Z-Score15.88
Beneish M-Score-2.24
1-Year Target Price24.24
Short Ratio4.12
Short % of Float11.25

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.73% 97 / 100   
1 Month -12.84% 25 / 100   
2 Months 11.86% 88 / 100   
6 Months 69.2% 97 / 100   
1 Year -7.82% 38 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog